Filing Details
- Accession Number:
- 0000899243-21-007455
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-19 19:27:31
- Reporting Period:
- 2021-02-17
- Accepted Time:
- 2021-02-19 19:27:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1815442 | Kymera Therapeutics Inc. | KYMR | Biological Products, (No Disgnostic Substances) (2836) | 812992166 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1821198 | Jared Gollob | C/O Kymera Therapeutics, Inc. 200 Arsenal Yards Blvd., Suite 230 Watertown MA 02472 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-02-17 | 7,550 | $58.39 | 99,997 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-18 | 6,499 | $55.94 | 93,498 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-02-19 | 8,887 | $55.09 | 84,611 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2020.
Billionaire Hedge Funds
